Lung Cancer Stage
By Bender Apps
Lung Cancer Stage is a medical reference tool for iOS that calculates lung cancer staging based on TNM classification criteria.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual TNM lookup during patient consultations by providing a rapid, point-of-care staging calculator.
For Medical students and healthcare professionals seeking a quick-reference tool for TNM lung cancer staging.
What does it look like?
Key features
Calculates lung cancer stage based on user-selected T, N, and M categories.
Provides quick-reference definitions for T, N, and M staging criteria.
Optimized interface for rapid educational access to staging concepts.
How much does it cost?
The app operates as a free educational utility with no visible monetization or paid tiers.
Velocity
Dormant developmentUX improvementsnew contentShow more...
With only one release in the observed window and no updates for 206 days, the app is currently in a zombie state. The latest version introduced a modernized interface and updated medical classification standards, but development has ceased since that time. There is no evidence of ongoing maintenance or active feature iteration.
Who built it?
Bender Apps
8 apps tracked · Medical
LIONS PREY
EuroSCORE II
SESATS 10
SESATS IX
Esophageal Cancer Stage
Oral Boards AI
Heart ChartUser Sentiment
What do users think recently?
Recent user voice shows a mixed sentiment. Users appreciate clinical staging utility provides rapid and accurate tnm classification for medical professionals in conferences.
How are ratings & reviews evolving?
What users say, by theme
- Clinical staging utility provides rapid and accurate TNM classification for medical professionals in conferences
- Inaccurate staging classifications for specific cancer stages cause confusion for medical professionals using the tool
5 of 5 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Lung Cancer Stage
How's the Medical market?
Lung Cancer Stage occupies a niche, free-to-use segment within the medical reference category. With a 3.25-star rating across a small sample of 4 reviews, the app's lack of recent updates relative to clinical standard changes limits its competitive standing against more frequently maintained medical databases.
The rivals identified
The Analyst's Read
Key takeaways for Lung Cancer Stage
Where is it heading?
The medical reference market demands high-frequency updates to align with evolving clinical standards. Lung Cancer Stage is currently failing this requirement, and the resulting accuracy concerns will likely accelerate user churn to more reliable, updated alternatives.
- The six-month update gap indicates a lack of active maintenance, which erodes professional trust in the tool's clinical accuracy.
- User reports of incorrect staging classifications suggest the app's core logic is failing to meet current medical requirements.
The SWOT
- Point-of-care reference design enables rapid staging access during clinical consultations
- Integrating visual anatomical diagrams would address the primary user request for improved staging clarity
Next best moves
Update TNM classification to the latest medical edition because current staging is outdated → restore clinical relevance
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of monetization is a liability, not an asset…
Read the full takeBottom line
Lung Cancer Stage requires an immediate update to the latest TNM classification standards to remain a viable clinical reference. Without this, the app risks total abandonment by its professional user base, as accuracy is the fundamental requirement for any medical tool.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated